| 51 |
27103451 | Microparticle Shedding by Erythrocytes, Monocytes and Vascular Smooth Muscular Cells Is Reduced by Aspirin in Diabetic Patients. | 2016 Jul |
1 |
| 52 |
27126722 | Update on the Management of Aspirin-Exacerbated Respiratory Disease. | 2016 Jul |
2 |
| 53 |
27129261 | Human Platelets Utilize Cycloxygenase-1 to Generate Dioxolane A3, a Neutrophil-activating Eicosanoid. | 2016 Jun 24 |
1 |
| 54 |
27393925 | The effectiveness of antioxidant therapy in aspirin resistance, diabetes population for prevention of thrombosis. | 2016 Oct |
5 |
| 55 |
27440714 | Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement. | 2016 Oct 28 |
1 |
| 56 |
27534531 | Aspirin induces IL-4 production: augmented IL-4 production in aspirin-exacerbated respiratory disease. | 2016 Jan 8 |
2 |
| 57 |
27633788 | Aspirin inhibits the production of proangiogenic 15(S)-HETE by platelet cyclooxygenase-1. | 2016 Dec |
3 |
| 58 |
27712763 | Pathogenesis of Aspirin-Induced Reactions in Aspirin-Exacerbated Respiratory Disease. | 2016 Nov |
1 |
| 59 |
27712764 | Performing Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease. | 2016 Nov |
1 |
| 60 |
27765537 | Aspirin, stroke and drug-drug interactions. | 2016 Dec |
1 |
| 61 |
25091345 | Low dose of acetylsalicylic acid and oxidative stress-mediated endothelial dysfunction in diabetes: a short-term evaluation. | 2015 Apr |
1 |
| 62 |
25267459 | Serum ubiquitin via CXC chemokine receptor 4 triggered cyclooxygenase-1 ubiquitination possibly involved in the pathogenesis of aspirin resistance. | 2015 |
2 |
| 63 |
25590318 | State of the Art: Medical treatment of aspirin exacerbated respiratory disease (AERD). | 2015 Jan-Feb |
4 |
| 64 |
25633316 | G-protein-coupled receptors signaling pathways in new antiplatelet drug development. | 2015 Mar |
1 |
| 65 |
25638730 | Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1. | 2015 Apr |
1 |
| 66 |
25663486 | Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD). | 2015 Mar |
3 |
| 67 |
25700561 | Current antiplatelet agents: place in therapy and role of genetic testing. | 2015 Apr |
1 |
| 68 |
25734355 | Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment. | 2015 |
1 |
| 69 |
25789542 | Prevention of dipyrone (metamizole) induced inhibition of aspirin antiplatelet effects. | 2015 Jul |
1 |
| 70 |
25869498 | A brief review on high on-aspirin residual platelet reactivity. | 2015 Apr-Jun |
1 |
| 71 |
26209241 | Aspirin provocation increases 8-iso-PGE2 in exhaled breath condensate of aspirin-hypersensitive asthmatics. | 2015 Sep |
1 |
| 72 |
26369686 | Low-Dose Aspirin-Associated Upper and Mid Gastrointestinal Tract Damage and Gene Polymorphism. | 2015 |
2 |
| 73 |
26475800 | Aspirin and spinal haematoma after neuraxial anaesthesia: Myth or reality? | 2015 Nov |
1 |
| 74 |
26517138 | The Implication of the Polymorphisms of COX-1, UGT1A6, and CYP2C9 among Cardiovascular Disease (CVD) Patients Treated with Aspirin. | 2015 |
3 |
| 75 |
26559689 | Vorapaxar in the secondary prevention of atherothrombosis. | 2015 Dec |
1 |
| 76 |
23677911 | Aspirin Half Maximal Inhibitory Concentration Value on Platelet Cyclooxygenase1 in Severe Type-2 Diabetes Mellitus is not Significantly Different from that of Healthy Individuals. | 2014 Sep |
1 |
| 77 |
23993980 | Mechanisms of aspirin resistance. | 2014 Jan |
2 |
| 78 |
24022862 | Suboptimal inhibition of platelet cyclooxygenase 1 by aspirin in systemic lupus erythematosus: association with metabolic syndrome. | 2014 Feb |
1 |
| 79 |
24207016 | Evaluation of laboratory methods routinely used to detect the effect of aspirin against new reference methods. | 2014 May |
5 |
| 80 |
24315499 | Appropriate assessment of the functional consequences of platelet cyclooxygenase-1 inhibition by aspirin in vivo. | 2014 May |
1 |
| 81 |
24432004 | The emerging role of oxylipins in thrombosis and diabetes. | 2014 Jan 7 |
1 |
| 82 |
24535852 | Novel non-synonymous polymorphisms in the COX-1 gene in Turkish pediatric patients with cardiovascular anomalies. | 2014 Jan 17 |
2 |
| 83 |
24748925 | Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery disease. | 2014 Apr 15 |
4 |
| 84 |
24890720 | Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease. | 2014 Jul 1 |
2 |
| 85 |
24930730 | Impacts of COX-1 gene polymorphisms on vascular outcomes in patients with ischemic stroke and treated with aspirin. | 2014 Aug 10 |
6 |
| 86 |
25385584 | Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs. | 2014 Nov 25 |
8 |
| 87 |
25624859 | Effect of common single nucleotide polymorphisms in COX-1 gene on related metabolic activity in diabetic patients treated with acetylsalicylic acid. | 2014 Dec 22 |
5 |
| 88 |
22609818 | Genetic polymorphisms of HO-1 and COX-1 are associated with aspirin resistance defined by light transmittance aggregation in Chinese Han patients. | 2013 Sep |
3 |
| 89 |
22882748 | Influence of non-steroidal anti-inflammatory drugs on antiplatelet effect of aspirin. | 2013 Feb |
1 |
| 90 |
23038044 | Frequency, risk factors, prognosis, and genetic polymorphism of the cyclooxygenase-1 gene for aspirin resistance in elderly Chinese patients with cardiovascular disease. | 2013 |
5 |
| 91 |
23384979 | Mechanism of the irreversible inhibition of human cyclooxygenase-1 by aspirin as predicted by QM/MM calculations. | 2013 Mar |
3 |
| 92 |
23422285 | New direct and indirect methods for the detection of cyclooxygenase 1 acetylation by aspirin; the lack of aspirin resistance among healthy individuals. | 2013 Apr |
5 |
| 93 |
23441755 | Low prostaglandin E2 and cyclooxygenase expression in nasal mucosa fibroblasts of aspirin-intolerant asthmatics. | 2013 May |
1 |
| 94 |
23639710 | Mechanisms of aspirin desensitization. | 2013 May |
2 |
| 95 |
23830213 | TXA2 synthesis and COX1-independent platelet reactivity in aspirin-treated patients soon after acute cerebral stroke or transient ischaemic attack. | 2013 Aug |
4 |
| 96 |
23883581 | Human platelets generate phospholipid-esterified prostaglandins via cyclooxygenase-1 that are inhibited by low dose aspirin supplementation. | 2013 Nov |
1 |
| 97 |
23985963 | Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction. | 2013 |
2 |
| 98 |
24075938 | Drug/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets. | 2013 Dec 5 |
5 |
| 99 |
24255997 | Mitigating the cardiovascular and renal effects of NSAIDs. | 2013 Dec |
1 |
| 100 |
22234683 | Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target. | 2012 Apr 12 |
1 |